Clinical Trials
7
Active:0
Completed:0
Trial Phases
2 Phases
Early Phase 1:5
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Early Phase 1
5 (71.4%)Not Applicable
2 (28.6%)Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer
Not Applicable
Not yet recruiting
- Conditions
- Gastric Cancer (GC)Colorectal Cancer
- Interventions
- First Posted Date
- 2025-09-10
- Last Posted Date
- 2025-09-10
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT07166263
- Locations
- 🇨🇳
Nanjing Drum Tower Hospital, Affiliated to the Medical School of Nanjing University, Nanjing, Jiangsu, China
NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus
Not Applicable
Not yet recruiting
- Conditions
- Refractory Systemic Lupus Erythematosus
- First Posted Date
- 2025-07-24
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT07083349
Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT06541405
- Locations
- 🇨🇳
Shanghai Children's Medical Center, Shanghai, Shanghai, China
Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia
- First Posted Date
- 2024-08-07
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 9
- Registration Number
- NCT06541444
- Locations
- 🇨🇳
Shanghai Pudong Hospital, Shanghai, Shanghai, China
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Base Therapeutics (Shanghai) Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06117878
- Locations
- 🇨🇳
Shanghai General Hospital, Shanghai, China
- Prev
- 1
- 2
- Next
News
No news found